Acquired Nephrogenic Diabetes Insipidus

Seminars in Nephrology

Volumn 26, Issue 3, 2006, Pages 244-248

  Khanna, Apurv ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

aquaporin 2; hypercalcemia; hypokalemia; lithium; Nephrogenic diabetes insipidus; vasopressin resistance

Indexed keywords

AMILORIDE; AMPHOTERICIN B; AQUAPORIN 1; AQUAPORIN 2; CIDOFOVIR; COLCHICINE; CONTRAST MEDIUM; DEMECLOCYCLINE; DESMOPRESSIN; FOSCARNET; IFOSFAMIDE; LITHIUM; MOOD STABILIZER; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; TETRAHYDROLIPSTATIN; THIAZIDE DIURETIC AGENT; VASOPRESSIN;

ARTICLE; DIETARY INTAKE; DRUG POTENTIATION; HUMAN; HYPERCALCEMIA; HYPOKALEMIA; METABOLIC DISORDER; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; TREATMENT OUTCOME; URINARY TRACT OBSTRUCTION; URINE OSMOLALITY; WATER DEPRIVATION;

AQUAPORINS; DIABETES INSIPIDUS, NEPHROGENIC; HUMANS; KIDNEY CONCENTRATING ABILITY;

EID: 33646533732     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2006.03.004     Document Type: Article

References (39)

1. Adam P. Evaluation and management of diabetes insipidus. Am Fam Physician 55 (1997) 2146-2153
2. Bendz H., Aurell M., and Lanke J. A historical cohort study of kidney damage in long-term lithium patients. Continued surveillance needed. Eur Psychiatry 16 (2001) 99-206
3. Garofeanu C.G., Weir M., Rosas-Arellano M.P., et al. Causes of reversible nephrogenic diabetes insipidus. A systematic review. Am J Kidney Dis 45 (2005) 626-637
4. Thompson C.G., France A.J., and Bayliss P.H. Persistent nephrogenic diabetes insipidus following lithium therapy. Scott Med J 42 (1997) 16-17
5. Bendz H., Sjodin I., and Aurell M. Renal function on and off lithium in patients treated with lithium for 5 years or more. A controlled, prospective lithium-withdrawal study. Nephrol Dial Transplant 11 (1996) 457-460
6. Agre P., Preston G.M., Smith B.L., et al. Aquaporin CHIP. the archetypal molecular water channel. Am J Physiol Renal Fluid Electrolyte Physiol 265 (1993) F463-F476
7. Nielson S., Froklaer J., Marples D., et al. Aquaporins in the kidney. From molecules to medicine. Physiol Rev 82 (2002) 205-244
8. Marples D., Frokiaer J., Knepper M.A., et al. Disordered water channel expression and distribution in acquired nephrogenic diabetes insipidus. Proc Assoc Am Physicians 110 (1998) 401-406
9. Knepper M.A., Neilsen S., Chou C.L., et al. Mechanism of vasopressin action in the renal collecting duct. Semin Nephrol 14 (1994) 302-321
10. Edwards R.M., Jackson B.M., and Dousa T.P. ADH-sensitive cAMP system in papillary collecting duct. effect of osmolality and PGE2. Am J Physiol 240 (1981) F311-F318
11. Katsura T., Gustafson C.E., Ausiello D.A., et al. Protein kinase A phosphorylation is involved in regulated exocytosis of aquaporin 2 in transfected LLC-PK1 cells. Am J Physiol 272 (1997) F817-F822
12. Fushimi K., Sasaki S., and Marumo F. Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin 2 water channel. J Biol Chem 272 (1997) 14800-14804
13. Valenti G., Hugon J.S., and Bourguet J. To what extent is microtubular network involved in antidiuretic response?. Am J Physiol 255 (1988) F1098-F1106
14. Marples D., Schroer T.A., Ahrens N., et al. Dynein and dynacatin colocalize with AQP2 water channels in intracellular vesicles from kidney collecting duct. Am J Physiol 274 (1998) F384-F394
15. Simon H., Gao Y., Franki N., et al. Vasopressin depolymerizes apical F-actin in rat inner medullary collecting duct. Am J Physiol 265 (1993) C757-C762
16. Franki N., Macaluso F., Gao Y., et al. Vesicle fusion proteins in rat inner medullary collecting duct and amphibian bladder. Am J Physiol 268 (1995) C792-C797
17. Strange K., Willingham M.C., Handler J.S., et al. Apical membrane endocytosis via coated pits is stimulated by removal of antidiuretic hormone from isolated, perfused rabbit cortical collecting tubule. J Membr Biol 103 (1988) 17-28
18. Rose B.D., and Post T.W. Clinical Physiology of Acid-Base and Electrolyte Disorders. (ed 5). (2001), McGraw-Hill, New York 148-757 767-772
19. Lanese D., and Teitelbaum I. Hypernatremia. In: Jacobson H.R., Stricker G.E., and Klahr S. (Eds). The Principles and Practice of Nephrology. (ed 2). (1995), Mosby, St. Louis 893
20. Peet M., and Pratt J.P. Lithium current status in psychiatric disorders. Drugs 46 (1993) 7-17
21. Boton R., Gaviria M., and Batlle D.C. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium. Lithium therapy. Am J Kidney Dis 10 (1987) 329-345
22. Kwon T.H., Laursen U.H., Marples D., et al. Altered expression of renal aquaporins and Na transporters in rats with lithium-induced nephrogenic diabetes insipidus. Am J Physiol 279 (2000) F552-F564
23. Marples D., Christensen S., Christensen E.I., et al. Lithium induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest 95 (1995) 1838-1845
24. Christensen S., Kusano E., Yusufi A.N., et al. Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats. J Clin Invest 75 (1985) 1869-1879
25. Matsumura Y., Uchida S., Rai T., et al. Transcriptional regulation of aquaporin-2 water channel gene by cAMP. J Am Soc Nephrol 8 (1997) 861-867
26. Marples D., Frokiaer J., Dorup J., et al. Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J Clin Invest 97 (1996) 1960-1968
27. Earm J.H., Christensen B.M., Frokiaer J., et al. Decreased aquaporin-2 expression and apical plasma membrane delivery in kidney collecting ducts of polyuric hypercalcemic rats. J Am Soc Nephrol 9 (1998) 2181-2193
28. Wang W., Kwon T.H., Li C., et al. Reduced expression of Na-K-2Cl cotransporter in medullary thick ascending limbs in vitamin D-induced hypercalcemia in rat. Am J Physiol (2002) F34-F44
29. Frokiaer J., Marples D., Knepper M.A., et al. Bilateral ureteral obstruction downregulates expression of vasopressin-sensitive AQP2 water channel in rat kidney. Am J Physiol 270 (1996) F657-F668
30. Frokiaer J., Christensen B.M., Marples D., et al. Downregulation of aquaporin-2 parallels changes in renal water excretion in unilateral ureteral obstruction. Am J Physiol 273 (1997) F213-F223
31. Nielsen S., Frokiaer J., Marples D., et al. Aquaporins in the kidney. From molecules to medicine. Physiol Rev 82 (2002) 205-244
32. Bendz H. Kidney function in a selected lithium population. A prospective, controlled, lithium-withdrawal study. Acta Psychiatr Scand 72 (1985) 451-463
33. Earley L.E., and Orloff J. The mechanism of antidiuresis associated with the administration of hydrochlorothiazide to patients with vasopressin-resistant diabetes insipidus. J Clin Invest 41 (1962) 1988
34. Knoers N., and Monnens L.A.H. Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus. J Pediatr 117 (1990) 499-502
35. Batlle D.C., Von Riotte A.B., Gaviria M., et al. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. N Engl J Med 312 (1985) 408
36. Lam S.S., and Kjellstrand C. Emergency treatment of lithium-induced diabetes insipidus with nonsteroidal anti-inflammatory drugs. Ren Fail 19 (1997) 183-188
37. Stokes J.B. Integrated actions of renal medullary prostaglandins in the control water excretion. Am J Physiol 240 (1981) F471
38. Miller M., Kalkos T., Moses A.M., et al. Recognition of partial defects in antidiuretic hormone secretion. Ann Intern Med 73 (1970) 721
39. Noda Y., and Sasaki S. Trafficking mechanism of water channel aquaporin-2. Biol Cell 97 (2005) 885-892